NEW YORK--(BUSINESS WIRE)--Aug 12, 2025--

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers and acquirers of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) common stock between May 12, 2022 and September 22, 2022, both dates inclusive (the “Class Period”). The lead plaintiff process was reopened by the Court. Before and during the Class Period, Spectrum Pharmaceuticals purported to be a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies.

For more information, submit a form , email attorney Phillip Kim, or give us a call at 866-767-3653.

The Allegations: Rosen Law Firm is Investigating the Allegations that Spectrum Pharmaceuticals, Inc. (NASDAQ: SP

See Full Page